BioNeutra Global Corporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CAD 24.115 million compared to CAD 37.700 million a year ago. Net loss was CAD 3.706 million compared to CAD 12.443 million a year ago. Basic loss per share from continuing operations was CAD 0.08 compared to CAD 0.27 a year ago.